Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts
Go back to Orhub’s Ryan Fernan Becomes Head Of Pur Biologics, Leading Regenerative Therapeutic Efforts| Baxter International Inc. (NYSE: BAX) | Delayed: 20.04 +0.38 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.66 | 52 Week High | $50.16 | |||
| Open | $19.50 | 52 Week Low | $34.06 | |||
| Day High | $20.05 | P/E | 5.48 | |||
| Day Low | $19.42 | EPS | $3.66 | |||
| Volume | 733,364 | |||||
| (AMEX: HSTO) | Delayed: 0.22 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.22 | 52 Week High | $ | |||
| Open | $0.22 | 52 Week Low | $ | |||
| Day High | $0.22 | P/E | N/A | |||
| Day Low | $0.22 | EPS | $ | |||
| Volume | 12,575 | |||||
